Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
| Revenue (TTM) | $12.26B |
| Gross Profit (TTM) | $3.05B |
| EBITDA | $2.92B |
| Operating Margin | 21.20% |
| Return on Equity | 9.72% |
| Return on Assets | 4.98% |
| Revenue/Share (TTM) | $22.26 |
| Book Value | $23.78 |
| Price-to-Book | 1.78 |
| Price-to-Sales (TTM) | 1.82 |
| EV/Revenue | 2.398 |
| EV/EBITDA | 10.20 |
| Quarterly Earnings Growth (YoY) | 4.10% |
| Quarterly Revenue Growth (YoY) | 2.20% |
| Shares Outstanding | $532.39M |
| Float | $472.02M |
| % Insiders | 7.58% |
| % Institutions | 51.92% |
Volatility is currently expanding
In October, we welcomed 25 new analysts to Seeking Alpha. This article showcases their stock picks and investment strategies. Analysts provided ratings from Sell to Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bullish views on lululemon athletica, McDonald's, Shoe Station, and the neocloud Nebius.
TORONTO--(BUSINESS WIRE)--Amrize is launching its ‘Made in Canada' label across its domestic cement manufacturing network, offering builders the assurance of Canadian-made manufacturing and quality, supporting local jobs and communities. As Canada's largest cement manufacturer with a highly efficient distribution and logistics network, Amrize is rolling out the ‘Made in Canada' label across its plants from Richmond, British Columbia and Exshaw, Alberta to Bath, Ontario and Brookfield, Nova Scot.
Amrize NYSE: AMRZ reported third-quarter revenue growth of 2.2% as pricing gains and acquisitions offset weather-related volume pressure across construction markets. Net income rose 3.3% to $558 million, while diluted earnings per share increased 4.1% to $1.02, Chairman and Chief Executive Officer Jan Jenisch said on the company's third-quarter earnings call.
Third-quarter net income increased 3.3% year over year to $558 million. Aggregates pricing increased 6.9% while cement pricing rose 1.8%.
Amrize AG ( AMRZ ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants Dillon Cumming - Vice President of Investor Relations Jan Jenisch - CEO & Chairman Samuel Poletti - Chief Financial Officer Conference Call Participants Anthony Pettinari - Citigroup Inc., Research Division Ethan Roberts - Stephens Inc., Research Division Bryan Blair - Oppenheimer & Co. Inc., Research Division Cedar Ekblom - Morgan Stanley, Research Division Garrett Samuel Greenblatt - JPMorgan Chase & Co, Research Division David S. MacGregor - Longbow Research LLC Julian Radlinger - UBS Investment Bank, Research Division Martin Huesler - Zürcher Kantonalbank, Research Division Yassine Touahri - On Field Investment Research LLP Presentation Operator Hello, and welcome to the Amrize's Q3 2026 Earnings Conference Call.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its third quarter 2026 financial results. Jan Jenisch, Chairman and CEO: "With the strength of our network and strategic footprint, we delivered resilient results in the third quarter. We increased revenue 2.2% on strong pricing and contributions from our recent acquisitions, even as weather patterns affected construction in the quarter. We grew Net Income by 3.3% to $558 million and increased Adjusted EBITDA to $1,076 m.
Investors need to pay close attention to AMRZ stock based on the movements in the options market lately.
Amrize Ltd (AMRZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its third quarter 2026 financial results after the U.S. market closes on Wednesday, October 28, 2026, followed by a live webcast to discuss the company's financial results at 7:30 am Central Time on Thursday, October 29, 2026. Registration for the live webcast can be completed at https://amrize-quarterly-results-q3-2026.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in t.
APLD, CVCO and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMRZ and any ticker you trade — then tracks every position and per-strategy win rate.
